These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 12640315)

  • 21. The effect of HLA mismatching on graft survival in living-donor kidney transplants: Catholic Medical Center, 1984 to 1993.
    Yoon YS; Jin DC; Yang CW; Kim SY; Bang BK; Kim WI; Koh YB
    Clin Transpl; 1993; ():275-83. PubMed ID: 7918161
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Kidney transplantation in the United States.
    Cecka JM
    Clin Transpl; 2008; ():1-18. PubMed ID: 19711510
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recurrence of IgA nephropathy among renal allograft recipients from living donors is greater among those with zero HLA mismatches.
    McDonald SP; Russ GR
    Transplantation; 2006 Sep; 82(6):759-62. PubMed ID: 17006322
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HLA amino acid residue matching.
    Takemoto SK
    Clin Transpl; 1996; ():397-425. PubMed ID: 9286585
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of human leukocyte antigen matching on liver allograft survival and rejection: "the dualistic effect".
    Donaldson P; Underhill J; Doherty D; Hayllar K; Calne R; Tan KC; O'Grady J; Wight D; Portmann B; Williams R
    Hepatology; 1993 Jun; 17(6):1008-15. PubMed ID: 8514248
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Renal after cardiothoracic transplant: the effect of repeat mismatches on outcome.
    Caskey FJ; Johnson RJ; Fuggle SV; Start S; Pugh D; Dudley CR
    Transplantation; 2009 Jun; 87(11):1727-32. PubMed ID: 19502967
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HLA matching: identification of permissible HLA mismatches.
    Maruya E; Takemoto S; Terasaki PI
    Clin Transpl; 1993; ():511-20. PubMed ID: 7918185
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The influence of HLA compatibility on graft survival after heart transplantation. The Collaborative Transplant Study.
    Opelz G; Wujciak T
    N Engl J Med; 1994 Mar; 330(12):816-9. PubMed ID: 8068075
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HLAMatchmaker-based strategy to identify acceptable HLA class I mismatches for highly sensitized kidney transplant candidates.
    Duquesnoy RJ; Witvliet M; Doxiadis II; de Fijter H; Claas FH
    Transpl Int; 2004 Jan; 17(1):22-30. PubMed ID: 12955350
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HLA compatibility and organ transplant survival. Collaborative Transplant Study.
    Opelz G; Wujciak T; Döhler B; Scherer S; Mytilineos J
    Rev Immunogenet; 1999; 1(3):334-42. PubMed ID: 11256424
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sensitization and crossmatch.
    Takemoto S
    Clin Transpl; 1995; ():417-32. PubMed ID: 8794284
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of HLA mismatches, shared cross-reactive antigen groups, and shared HLA-DR antigens on the outcome after pediatric liver transplantation.
    Sieders E; Hepkema BG; Peeters PM; TenVergert EM; de Jong KP; Porte RJ; Bijleveld CM; van den Berg AP; Lems SP; Gouw AS; Slooff MJ
    Liver Transpl; 2005 Dec; 11(12):1541-9. PubMed ID: 16315307
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Histoincompatibilities in ABDR-matched unrelated donor recipient combinations.
    Rufer N; Tiercy JM; Breur-Vriesendorp B; Gauchat-Feiss D; Shi X; Slavcev A; Lardy N; Speiser D; Gratwohl A; Chapuis B
    Bone Marrow Transplant; 1995 Nov; 16(5):641-6. PubMed ID: 8547860
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of human leukocyte antigen matching on long-term outcome after lung transplantation.
    Wisser W; Wekerle T; Zlabinger G; Senbaclavaci O; Zuckermann A; Klepetko W; Wolner E
    J Heart Lung Transplant; 1996 Dec; 15(12):1209-16. PubMed ID: 8981206
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HLA-DR mismatching correlates with early cardiac allograft rejection, incidence, and graft survival when high-confidence-level serological DR typing is used.
    De Mattos AM; Head MA; Everett J; Hosenpud J; Hershberger R; Cobanoglu A; Ott G; Ratkovec R; Norman DJ
    Transplantation; 1994 Feb; 57(4):626-30. PubMed ID: 8116051
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transplantation results of completely HLA-mismatched living and completely HLA-matched deceased-donor kidneys are comparable.
    Laging M; Kal-van Gestel JA; Haasnoot GW; Claas FH; van de Wetering J; Ijzermans JN; Weimar W; Roodnat JI
    Transplantation; 2014 Feb; 97(3):330-6. PubMed ID: 24202143
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of HLA class I (A and B) and class II (DR) compatibility on liver transplantation outcomes: an analysis of the OPTN database.
    Navarro V; Herrine S; Katopes C; Colombe B; Spain CV
    Liver Transpl; 2006 Apr; 12(4):652-8. PubMed ID: 16555339
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of HLA matching on the outcome of simultaneous pancreas-kidney transplantation.
    Berney T; Malaise J; Morel P; Toso C; Demuylder-Mischler S; Majno P; Bühler LH; Mentha G;
    Nephrol Dial Transplant; 2005 May; 20 Suppl 2():ii48-53, ii62. PubMed ID: 15814550
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sensitization 2001.
    Hardy S; Lee SH; Terasaki PI
    Clin Transpl; 2001; ():271-8. PubMed ID: 12211790
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Simpler and equitable allocation of kidneys from postmortem donors primarily based on full HLA-DR compatibility.
    Doxiadis II; de Fijter JW; Mallat MJ; Haasnoot GW; Ringers J; Persijn GG; Claas FH
    Transplantation; 2007 May; 83(9):1207-13. PubMed ID: 17496537
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.